Prectival 402 mg ml Spot-on Solution for Dogs

Main information

  • Trade name:
  • Prectival 402 mg ml Spot-on Solution for Dogs
  • Pharmaceutical form:
  • Spot-on solution
  • Medicine domain:
  • Animals
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • Prectival 402 mg ml Spot-on Solution for Dogs
    Netherlands
  • Language:
  • English

Therapeutic information

  • Therapeutic group:
  • fipronil
  • Therapeutic area:
  • Dogs

Other information

Status

  • Source:
  • HMA - Europe
  • Authorization number:
  • UK/V/0381/005
  • Authorization date:
  • 28-09-2011
  • EU code:
  • UK/V/0381/005
  • Last update:
  • 09-08-2016

Summary of Product characteristics: dosage,interactions,side effects

Issued:November2011

AN:00587/2010

Page1of7

SUMMARYOFPRODUCTCHARACTERISTICS

1. NAMEOFTHEVETERINARYMEDICINALPRODUCT

Eliminall402mgspot-onsolutionfordogs

Exprolinevet402mgspot-onsolutionfordogs

Eliminall402mgspot-onsolutionfordogs(Austria,France,Germany,Greece,Italy,

Ireland,Luxemburg,Netherlands,UnitedKingdom,Portugal,Spain)

Exprolinevet402mgspot-onsolutionfordogs(Norway,Denmark,Finland,Sweden)

2. QUALITATIVEANDQUANTITATIVECOMPOSITION

1pipette(4.02ml)contains:

Activesubstance:

Fipronil 402mg

Excipients:

Butylhydroxyanisole(E320) 0.80mg

Butylhydroxytoluene(E321) 0.40mg

Forafulllistofexcipients,seesection6.1.

3. PHARMACEUTICALFORM

Spot-onsolution.

Lightyellowtoyellow,clearliquid.

4. CLINICALPARTICULARS

4.1 Targetspecies

Dogs

4.2 Indicationsforuse,specifyingthetargetspecies

Treatmentofflea(Ctenocephalidesspp.)andtick(Dermacentorreticulatus)

infestations.

FortreatmentofTrichodectescanisbitingliceinfestationsondogs.Mostliceare

killedwithin2days.

Insecticidalefficacyagainstnewinfestationswithadultfleaspersistsforupto8

weeks.

Issued:November2011

AN:00587/2010

Page2of7

Theproducthasapersistentacaricidalefficacyforupto3weeksagainstIxodes

ricinusandupto4weeksagainstRhipicephalussanguineusandDermacentor

reticulatus.Ifticksofsomespecies(Ixodesricinus,Rhipicephalussanguineus)are

presentwhentheproductisapplied,alltheticksmaynotbekilledwithinthefirst48

hours.

TheproductcanbeusedaspartofatreatmentstrategyforthecontrolofFleaAllergy

Dermatitis(FAD)wherethishasbeenpreviouslydiagnosedbyaveterinarysurgeon.

4.3 Contraindications

Donotuseonpuppieslessthan2monthsoldand/orweighinglessthan2kginthe

absenceofavailabledata.

Donotuseonsick (e.g.systemicdiseases,fever…)orconvalescentanimals.

Donotuseinrabbits,asadversereactionsandevendeathcouldoccur.

Thisproductisspecificallydevelopedfordogs.Donotuseincats,asthiscouldlead

tooverdosing.

Donotuseincasesofhypersensitivitytotheactivesubstance,dimethylsulphoxide

ortoanyofotherexcipients.

4.4 Specialwarningsforeachtargetspecies

Bathing/immersioninwaterwithintwodaysafterapplicationoftheproductshouldbe

avoided.Afterweeklyimmersionsinwaterforoneminutetheperiodofpersistent

insecticidalefficacyagainstfleaswas7weeks.

Theproductdoesnotpreventticksfromattachingtotheanimals.Iftheanimalhas

beentreatedpriortoexposuretotheticks,thetickswillbekilledinthefirst24-48

hoursafterattachment.Thiswillusuallybepriortoengorgement,minimisingbutnot

excludingtheriskoftransmissionofdiseases.Oncedead,tickswilloftendropoffthe

animal,butanyremainingticksmayberemovedwithagentlepull.

Fleasfrompetsofteninfesttheanimal'sbasket,beddingandregularrestingareas

suchascarpetsandsoftfurnishingswhichshouldbetreated,incaseofmassive

infestationandatthebeginningofthecontrolmeasures,withasuitableinsecticide

andvacuumedregularly.

WhenusedaspartofastrategyforthetreatmentoffleaAllergyDermatitis,monthly

applicationstotheallergicpatientandtootherdogsinthehouseholdare

recommended.

Foroptimalcontroloffleainfestationinmulti-pethousehold,alldogsandcatsinthe

householdshouldbetreatedwithasuitableinsecticide.

Issued:November2011

AN:00587/2010

Page3of7

4.5 Specialprecautionsforuse

i)Specialprecautionsforuseinanimals

Animalsshouldbeweighedaccuratelypriortotreatment.

Avoidcontactwiththeanimal'seyes.Inthecaseofaccidentaleyecontact,

immediatelyandthoroughlyflushtheeyeswithwater.

Itisimportanttomakesurethattheproductisappliedtoanareawheretheanimal

cannotlickitoffandtomakesurethatanimalsdonotlickeachotherfollowing

treatment.

Donotapplytheproductonwoundsordamagedskin.

ii)Specialprecautionstobetakenbythepersonadministeringtheveterinary

medicinalproducttoanimals

Thisproductcancausemucousmembraneandeyeirritation.Therefore,contact

betweentheproductandthemouthoreyesshouldbeavoided.

Inthecaseofaccidentaleyecontactimmediatelyandthoroughlyflushtheeyeswith

water.Ifeyeirritationpersistsseekmedicaladviceandshowthepackageleafletor

thelabeltothephysician.

Donotsmoke,drinkoreatduringapplication.

Avoidcontentscomingintocontactwiththefingers.Ifthisoccurs,washoff

immediatelywithsoapandwater.

Washhandsafteruse.

Peoplewithaknownhypersensitivitytofipronilordimethylsulphoxideorother

excipientsshouldavoidcontactwiththeveterinarymedicinalproduct.

Treatedanimalsshouldnotbehandleduntiltheapplicationsiteisdry,andchildren

shouldnotbeallowedtoplaywithtreatedanimalsuntiltheapplicationsiteisdry.Itis

thereforerecommendedthatanimalsarenottreatedduringtheday,butshouldbe

treatedduringtheearlyevening,andthatrecentlytreatedanimalsshouldnotbe

allowedtosleepwithowners,especiallychildren.

iii)Otherprecautions

Fipronilmayadverselyaffectaquaticorganisms.Dogsshouldnotbeallowedtoswim

inwatercoursesfor2daysafterapplication.

4.6Adversereactions(frequencyandseriousness)

Iflickingoccurs,abriefperiodofhypersalivationmaybeobserved.

Amongtheextremelyraresuspectedadversereactions,transientcutaneous

reactionsontheapplicationsite(skindiscoloration,localalopecia,pruritus,

erythema)andgeneralpruritusoralopeciahavebeenreportedafteruse.

Exceptionally,hypersalivation,reversibleneurologicsymptoms(hyperesthesia,

depression,nervoussymptoms),vomitingorrespiratorysymptomshavebeen

observedafteruse.

Issued:November2011

AN:00587/2010

Page4of7

4.7 Useduringpregnancy,lactationorlay

Laboratorystudiesusingfipronilhavenotshownanyevidenceofteratogenicor

embryotoxiceffect.Studieshavenotbeencarriedoutwiththisproductinpregnant

andlactatingbitches.Useinpregnancyandlactationonlyinaccordancewith

professionalveterinaryadviceandabenefit/riskassessment.

4.8Interactionwithothermedicinalproductsandotherformsofinteraction

Noneknown.

4.9 Amountstobeadministeredandadministrationroute

Routeofadministrationanddosage:

Externaluseonly.

Administerbytopicalapplicationtotheskinaccordingtothebodyweightasfollows:

1pipetteof4.02mlperdogweighingover40kgupto60kgbodyweight,andone

pipetteof4.02mlandanappropriatesmallerpipetteperdogweighingover60kg

bodyweight.

Methodofadministration:

Removethepipettefromthetriplexbag.Holdthepipetteinanuprightposition,twist

andpullthecapoff.Turnthecaparoundandplacetheotherendofthecapbackon

thepipette.Pushandtwistthecaptobreaktheseal,thenremovethecapfromthe

pipette.Spreadtheanimalhairsintheareabetweentheshoulderbladestomakethe

skinvisible.Putthetipofthepipetteontotheskinandpresstheunit-dosepipette

severaltimestoemptyitscontentsdirectlyontotheskinatoneortwospots.

Itisimportanttomakesurethattheproductisappliedtoanareawheretheanimal

cannotlickitoff,andtomakesurethatanimalsdonotlickeachotherfollowing

treatment.

Thehairshouldbepartedandtheproductappliedtotheskin.Temporarychangesto

thecoat(clumped/greasyhairand/ordepositsonthehair)maybenotedatthe

applicationsite.

Treatmentschedule:

Foroptimalcontroloffleaand/ortickinfestationthetreatmentschedulecanbebased

onthelocalepidemiologicalsituation.

Intheabsenceofsafetystudies,theminimumtreatmentintervalis4weeks.

Issued:November2011

AN:00587/2010

Page5of7

4.10Overdose(symptoms,emergencyprocedures,antidotes),ifnecessary

Noadverseeffectswereobservedintargetanimalsafetystudiesin8week-old

puppies,growingdogsanddogsweighingabout2kgtreatedonceatfivetimesthe

recommendeddose.Theriskofexperiencingadverseeffects(seesection4.6)may

howeverincreasewhenoverdosing,soanimalsshouldalwaysbetreatedwiththe

correctpipettesizeaccordingtobodyweight.

4.11Withdrawalperiod

Notapplicable.

5. PHARMACOLOGICALPROPERTIES

Pharmacotherapeuticgroup:Ectoparasiticidesfortopicaluse.

ATCvetcode:QP53AX15

5.1 Pharmacodynamicproperties

Fipronilisaninsecticideandacaricidebelongingtothephenylpyrazolefamily.Itacts

byinhibitingtheGABAcomplex,bindingtothechloridechannelandtherebyblocking

pre-andpost-synaptictransferofchlorideionsacrosscellmembranes.Thisresultsin

uncontrolledactivityofthecentralnervoussystemanddeathofinsectsoracarids.

Fipronilexhibitsaninsecticidalandacaricidalactivityagainstfleas(Ctenocephalides

spp),ticks(Rhipicephalusspp,Dermacentorspp,IxodessppincludingIxodes

ricinus,andlice(Trichodectescanis)inthedog.Tickswillusuallybekilledwithin48h

aftercontactwithFipronil,howeverifticksofsomespecies(Ixodesricinus,

Rhipicephalussanguineus)arealreadypresentwhentheproductisapplied,allofthe

ticksmaynotbekilledwithinthefirst48hours.Fleaswillbekilledwithin24hours.

5.2 Pharmacokineticproperties

Fipronilismainlymetabolisedtoitssulfonederivative(RM1602),whichalso

possessesinsecticidalandacaricidalproperties.Theconcentrationsoffipronilonthe

hairdecreasewithtime.

6. PHARMACEUTICALPARTICULARS

6.1Listofexcipients

Butylhydroxyanisole(E320)

Butylhydroxytoluene(E321)

Polysorbate80

PovidoneK25

Dimethylsulfoxide

Issued:November2011

AN:00587/2010

Page6of7

6.2Incompatibilities

Noneknown.

6.3Shelflife

Shelf-lifeoftheveterinarymedicinalproductaspackagedforsale:36months.

6.4.Specialprecautionsforstorage

Storeintheoriginalcontainerinordertoprotectfromlightandmoisture.

6.5Natureandcompositionofimmediatepackaging

Whitepolypropylenepipetteclosedwitheitherapolyethyleneorpolyoxymethylene

cap.Eachpipetteispackedinapolyethyleneterephthalate/aluminium/lowdensity

polyethylenetriplexbag.

Boxcontaining1,3,6,10,20or30pipettes.

Notallpacksizesmaybemarketed.

6.6 Specialprecautionsforthedisposalofunusedveterinarymedicinal

productorwastematerialsderivedfromtheuseofsuchproducts

Anyunusedveterinarymedicinalproductorwastematerialsderivedfromsuch

veterinarymedicinalproductsshouldbedisposedofinaccordancewithlocal

requirements.

Fipronilmayadverselyaffectaquaticorganisms.Donotcontaminateponds,waterways

orditcheswiththeproductoremptycontainer.

Issued:November2011

AN:00587/2010

Page7of7

7. MARKETINGAUTHORISATIONHOLDER

KRKA,d.d.,Novomesto

Šmarješkacesta6

8501Novomesto

Slovenia

8. MARKETINGAUTHORISATIONNUMBER

Vm01656/4033

9. DATEOFFIRSTAUTHORISATION

15November2011

10. DATEOFREVISIONOFTHETEXT

November2011

11-9-2018

Risk assessment of antimicrobial resistance along the food chain through culture‐independent methodologies

Risk assessment of antimicrobial resistance along the food chain through culture‐independent methodologies

Published on: Mon, 27 Aug 2018 00:00:00 +0200 Antimicrobial resistance (AMR) represents a major challenge for Public Health and the scientific community, and requires immediate and drastic solutions. Acquired resistance to certain antimicrobials is already widespread to such an extent that their efficacy in the treatment of certain life‐threatening infections is already compromised. To date, the emergence and spread of AMR has been attributed to the use, misuse or indiscriminate use of antibiotics as th...

Europe - EFSA - European Food Safety Authority Publications

There are no news related to this product.